Objective To investigate the differences in clinical features of childhood purulent meningitis (PM) caused by Escherichia coli and Streptococcus pneumoniae, and to provide help for the selection of antibiotics for PM children with unknown etiology. Methods A retrospective analysis was performed for the clinical data of children with PM caused by Escherichia coli (12 children) or Streptococcus pneumoniae (15 children). Results Compared with the Streptococcus pneumoniae infection group, the Escherichia coli infection group had a significantly higher proportion of children with an age of onset of <3 months and a significantly higher incidence rate of convulsion, but significantly lower incidence rates of severe fever (>39°C) and disturbance of consciousness and a significantly lower proportion of children with an increased leukocyte count at diagnosis (>12×109/L). The results of routine cerebrospinal fluid test and biochemical examinations showed no significant differences between the two groups. Escherichia coli and Streptococcus pneumoniae were resistant to cephalosporins and had a sensitivity to chloramphenicol more than 90%. Escherichia coli was fully sensitive to meropenem and Streptococcus pneumoniae was fully sensitive to vancomycin. Conclusions PM caused by Escherichia coli and Streptococcus pneumoniae has different clinical features. As for PM children with severe fever, disturbance of consciousness, and an increased leukocyte count, the probability of Streptococcus pneumoniae infection should be considered. For PM children with an age of onset of <3 months, medium- and low-grade fever, frequent convulsions, and a leukocyte count of <12×109/L, the probability of Escherichia coli infection should be considered.
Key words
Escherichia coli /
Streptococcus pneumoniae /
Purulent meningitis /
Clinical feature /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Amarilyo G, Alper A, Ben-Tov A, et al. Diagnostic accuracy of clinical symptoms and signs in children with meningitis[J]. Pediatr Emerg Care, 2011, 27(3): 196-199.
[2] Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from communitybased studies[J]. Pediatr Infect Dis J, 2009, 28(1 Suppl): S3-S9.
[3] Molyneux E, Riordan FA, Walsh A. Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference[J]. Ann Trop Paediatr, 2006, 26(1): 29-37.
[4] 刘钢, 张二清, 陈荷英, 等. 儿童化脓性脑膜炎不良预后危险因素探讨[J]. 临床儿科杂志, 2011, 29(2): 148-152.
[5] 王艺, 王传清, 王晓红. 细菌性脑膜炎 266 例病原学与耐药性分析[J]. 实用儿科临床杂志, 2006, 21(6): 355-356.
[6] 樊寻梅, 周永涛. 化脓性脑膜炎 [M] // 胡亚美, 江载芳. 诸福棠实用儿科学. 第7 版. 北京: 人民卫生出版社, 2003: 912- 926.
[7] Brauteset LV, Høiby EA, Syversen G, et al. Invasive pneumoccal disease in children in Oslo 1998-2004[J]. Tidsskr Nor Laegeforen, 2008, 128 (12): 1380-1383.
[8] 张晓莉, 贾天明, 牛国辉, 等. 氯霉素治疗小儿难治性化脓性脑膜炎的疗效和安全性分析[J]. 中国妇幼保健, 2014, 29 (8): 1281-1283.
[9] Braun V, Eskens U, Hartmann A, et al. Focal bacterial meningitis following ascending bite wound infection leading to paraparesis in a captive California sea lion (Zalophus californianus)[J]. J Zoo Wildl Med, 2015, 46(1): 135-140.
[10] Lynch JP, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines[J]. Curr Opin Pulm Med, 2010, 16(3): 217- 225.
[11] Cardozo DM, Nascimento-Carvalho CM, Andrade AL, et al. Prevalence and risk factors for nasopharyngeal carriage of Streptococcus pneumoniae among adolescents[J]. J Med Microbiol, 2008, 57(Pt 2): 185-189.
[12] 朱敏丽, 林振浪, 林锦. 新生儿大肠埃希菌败血症临床及耐药性变迁分析 [J]. 中国新生儿科杂志, 2009, 24(4): 217-219.
[13] Tsumura R, Ikawa K, Morikawa N, et al. The pharmacokinetics and pharmacodynamics of meropenem in the cerebrospinal fluid of neurosurgical patients[J]. J Chemother, 2008, 20(5): 615-621.
[14] Kim KS. Acute bacterial meningitis in infants and children[J]. Lancet Infect Dis, 2010, 10(1): 32-42.
PDF(1043 KB)
